Dendrimers—revolutionary drugs for infectious diseases
Identifieur interne : 000B28 ( Main/Exploration ); précédent : 000B27; suivant : 000B29Dendrimers—revolutionary drugs for infectious diseases
Auteurs : Joanna Lazniewska [Pologne] ; Katarzyna Milowska [Pologne] ; Teresa Gabryelak [Pologne]Source :
- Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology [ 1939-5116 ] ; 2012-09.
Abstract
Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 For further resources related to this article, please visit the WIREs website.
Url:
DOI: 10.1002/wnan.1181
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001183
- to stream Istex, to step Curation: 001183
- to stream Istex, to step Checkpoint: 000105
- to stream Main, to step Merge: 000B31
- to stream Main, to step Curation: 000B28
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dendrimers—revolutionary drugs for infectious diseases</title><author><name sortKey="Lazniewska, Joanna" sort="Lazniewska, Joanna" uniqKey="Lazniewska J" first="Joanna" last="Lazniewska">Joanna Lazniewska</name></author><author><name sortKey="Milowska, Katarzyna" sort="Milowska, Katarzyna" uniqKey="Milowska K" first="Katarzyna" last="Milowska">Katarzyna Milowska</name></author><author><name sortKey="Gabryelak, Teresa" sort="Gabryelak, Teresa" uniqKey="Gabryelak T" first="Teresa" last="Gabryelak">Teresa Gabryelak</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9831976E5B4267DD17E6ED28BFECEFD141B6FED3</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1002/wnan.1181</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-GGNMRLN8-Z/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001183</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001183</idno><idno type="wicri:Area/Istex/Curation">001183</idno><idno type="wicri:Area/Istex/Checkpoint">000105</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000105</idno><idno type="wicri:doubleKey">1939-5116:2012:Lazniewska J:dendrimers:revolutionary:drugs</idno><idno type="wicri:Area/Main/Merge">000B31</idno><idno type="wicri:Area/Main/Curation">000B28</idno><idno type="wicri:Area/Main/Exploration">000B28</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Dendrimers—revolutionary drugs for infectious diseases</title><author><name sortKey="Lazniewska, Joanna" sort="Lazniewska, Joanna" uniqKey="Lazniewska J" first="Joanna" last="Lazniewska">Joanna Lazniewska</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of General Biophysics, University of Lodz, Lodz</wicri:regionArea><wicri:noRegion>Lodz</wicri:noRegion></affiliation><affiliation></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Correspondence address: Department of General Biophysics, University of Lodz, Lodz</wicri:regionArea><wicri:noRegion>Lodz</wicri:noRegion></affiliation></author><author><name sortKey="Milowska, Katarzyna" sort="Milowska, Katarzyna" uniqKey="Milowska K" first="Katarzyna" last="Milowska">Katarzyna Milowska</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of General Biophysics, University of Lodz, Lodz</wicri:regionArea><wicri:noRegion>Lodz</wicri:noRegion></affiliation></author><author><name sortKey="Gabryelak, Teresa" sort="Gabryelak, Teresa" uniqKey="Gabryelak T" first="Teresa" last="Gabryelak">Teresa Gabryelak</name><affiliation wicri:level="1"><country xml:lang="fr">Pologne</country><wicri:regionArea>Department of General Biophysics, University of Lodz, Lodz</wicri:regionArea><wicri:noRegion>Lodz</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology</title><title level="j" type="alt">WILEY INTERDISCIPLINARY REVIEWS: NANOMEDICINE AND NANOBIOTECHNOLOGY</title><idno type="ISSN">1939-5116</idno><idno type="eISSN">1939-0041</idno><imprint><biblScope unit="vol">4</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="469">469</biblScope><biblScope unit="page" to="491">491</biblScope><biblScope unit="page-count">23</biblScope><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>Hoboken, USA</pubPlace><date type="published" when="2012-09">2012-09</date></imprint><idno type="ISSN">1939-5116</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1939-5116</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Over recent years innovative nanomolecules in a form of dendrimers have been gaining increasing interest. These compounds can be designed and modified in many ways giving a molecule which meets required expectations. For this reason dendrimers are the object of intensive studies in many fields of nanoscience including one of the most thriving—biomedicine. Numerous studies provide evidence that some dendrimers exhibit activities against many species/strains of viruses, bacteria, fungi, and prions. These types of dendritic nanostructures which are distinguished by antipathogenic properties and low cytotoxicity to eukaryotic cells may be potentially applied in medicine as novel drugs for various infectious diseases, especially those which are persistent, marked by high mortality rate, or untreatable. Dendrimers can exert their effect via different mechanisms of action, which are, in most cases, related to multivalency of the nanomolecule. The application of dendrimers is likely to be a breakthrough in prevention and treatment of infectious diseases which still beset humanity and may significantly improve the quality of people's life. WIREs Nanomed Nanobiotechnol 2012, 4:469–491. doi: 10.1002/wnan.1181 For further resources related to this article, please visit the WIREs website.</div></front></TEI><affiliations><list><country><li>Pologne</li></country></list><tree><country name="Pologne"><noRegion><name sortKey="Lazniewska, Joanna" sort="Lazniewska, Joanna" uniqKey="Lazniewska J" first="Joanna" last="Lazniewska">Joanna Lazniewska</name></noRegion><name sortKey="Gabryelak, Teresa" sort="Gabryelak, Teresa" uniqKey="Gabryelak T" first="Teresa" last="Gabryelak">Teresa Gabryelak</name><name sortKey="Lazniewska, Joanna" sort="Lazniewska, Joanna" uniqKey="Lazniewska J" first="Joanna" last="Lazniewska">Joanna Lazniewska</name><name sortKey="Milowska, Katarzyna" sort="Milowska, Katarzyna" uniqKey="Milowska K" first="Katarzyna" last="Milowska">Katarzyna Milowska</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B28 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B28 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:9831976E5B4267DD17E6ED28BFECEFD141B6FED3
|texte= Dendrimers—revolutionary drugs for infectious diseases
}}
| This area was generated with Dilib version V0.6.33. |  |